Rigel Pharmaceuticals (RIGL) Capital Expenditures Growth (3y) (2013 - 2025)
Rigel Pharmaceuticals (RIGL) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Rigel Pharmaceuticals |
603.18 Mn |
456.49 Mn |
54.21 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-29.35% |
| Dec 31, 2024 |
47.94% |
| Dec 31, 2022 |
-50.75% |
| Sep 30, 2022 |
-18.72% |
| Jun 30, 2022 |
-32.25% |
| Mar 31, 2022 |
-15.93% |
| Dec 31, 2021 |
-32.08% |
| Sep 30, 2021 |
2.91% |
| Jun 30, 2021 |
-15.89% |
| Mar 31, 2021 |
-28.84% |
| Dec 31, 2020 |
111.86% |
| Sep 30, 2020 |
51.57% |
| Jun 30, 2020 |
-72.61% |
| Mar 31, 2020 |
145.55% |
| Dec 31, 2019 |
366.98% |
| Sep 30, 2019 |
11.78% |
| Jun 30, 2019 |
-20.05% |
| Mar 31, 2019 |
5.51% |
| Dec 31, 2018 |
-19.85% |
| Sep 30, 2018 |
-20.20% |
